Search
Home
>>
What's New
What's new
SFDA Commissioner Shao Mingli meets with Canadian delegation
(2006-06-19)
China-made oseltamivir phosphate approved by SFDA
(2006-06-16)
SFDA's Center for Drug Reevaluation formally functions as the National Center for ADR Monitoring
(2006-06-12)
SFDA issues requirements for medical device distributors setting up warehouses out of the province where they are located
(2006-06-12)
SFDA to launch an intensive publicity campaign for "safe and rational drug use"
(2006-06-09)
SFDA invites public comments on the format of the insert sheets for prescription TCM and natural medicine
(2006-06-09)
China launches campaigns to rectify and standardize the drug market order
(2006-06-08)
Mr. Shao Mingli meets Deputy Commissioner of US FDA
(2006-06-02)
SFDA issues the No. 88 announcement of drug administrative protection
(2006-05-31)
SFDA specifies requirements for drug names used in advertisements
(2006-05-30)
SFDA issues outlines of publicity and training for the "Two Networks" of drugs in rural areas
(2006-05-26)
SFDA issues 2006 Project Plan of Setting and Revising Industry Standards for Medical Devices
(2006-05-24)
SFDA rescinds 51 industry standards for medical devices
(2006-05-24)
SFDA issues the First Summary of Announcements Regarding Illegal Drug Advertisements in 2006
(2006-05-24)
SFDA requires further intensifying the supervision and management of drug manufacturers
(2006-05-23)
SFDA issues detailed specifications on the insert sheet of chemical drugs and biological products
(2006-05-23)
Shao Mingli: Establish and implement a scientific concept of supervision and ensure food and drug safety for the public
(2006-05-22)
SFDA issues Interim Requirements for Unannounced GMP Inspections for Human Drugs
(2006-05-19)
SFDA invites comments on general principles of Criterion for Medical Device Quality System Management
(2006-05-19)
SFDA issues a notice regarding the registration of medical electrical equipment
(2006-05-19)
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Next >
(17/30)